Plasmodium falciparum: stage-related expression of topoisomerase I.
The expression and activity of topoisomerase I (PfTopoI) has been examined during the intraerythrocytic stages of the Plasmodium falciparum life cycle. The promoter is inactive during the early ring stage and becomes active only during the later trophozoite and schizont stages. The PfTOP1 transcript starts to accumulate in the trophozoite stage parasite, decreasing again in the schizont stage. Using both stage-specific Western analysis and immunofluorescent assays we show that PfTopoI is present at low levels in rings and accumulates to approximately equal levels in the trophozoite and schizont stages. Experiments to determine the activity of PfTopoI, using a topoisomerase I relaxation assay, show that there is a low level of PfTopoI activity in both ring and trophozoite stages, but activity increases dramatically in the schizont stage. The PfTopoI activity can be inhibited by treatment with specific antiserum and by the type I topoisomerase-specific inhibitor camptothecin.
Tosh
K
K
Institute of Cell and Molecular Biology, University of Edinburgh, United Kingdom.
Cheesman
S
S
Horrocks
P
P
Kilbey
B
B
D000818:Animals; D000913:Antibodies, Protozoan / Q000737:chemistry; D015152:Blotting, Northern; D015153:Blotting, Western; D002166:Camptothecin / Q000494:pharmacology; D004264:DNA Topoisomerases, Type I / Q000235:genetics* / Q000378:metabolism; D016054:DNA, Protozoan / Q000737:chemistry; D004587:Electrophoresis, Agar Gel; D004591:Electrophoresis, Polyacrylamide Gel; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D015971:Gene Expression Regulation, Enzymologic; D016778:Malaria, Falciparum / Q000201:enzymology / Q000469:parasitology; D009693:Nucleic Acid Hybridization; D010963:Plasmodium falciparum / Q000187:drug effects / Q000201:enzymology / Q000235:genetics*; D011401:Promoter Regions, Genetic / Q000502:physiology; D011817:Rabbits